Dr Mark Payton interview with ProActive

CEO Dr Mark Payton joined Proactive’s Stephen Gunnion to talk through Mercia’s FY25 Interim Results which showcased strong growth and operational milestones. Dr Payton reflected on a decade of accomplishments since Mercia’s listing, highlighting £1.6 billion in third-party funds under management and investments of over £1 billion across the UK, predominantly outside London. .

Mercia announces Interim Results FY2025

Mercia Asset Management PLC is pleased to announce its interim results for the six months ended 30 September 2024. Mark Payton, Chief Executive Officer of Mercia, commented: “Mercia has delivered another strong first half performance with our higher funds under management driving revenue and EBITDA growth. I am pleased to say that none of the

Tagomics announces a multiomic profiling co-marketing agreement with Agilent

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in the genomics sector. The agreement offers select customers the opportunity to access Tagomics’ and Agilent Technologies’ combined innovative offerings through an exclusive technology access program hosted out of

Scalpel AI raises £3.8m to transform surgical logistics

Scalpel AI, a London-based medtech start-up transforming the management of surgical tools and implants using computer vision, has raised £3.8m ($4.8m) in a funding round led by Mercia Ventures, with participation from Tensor Ventures and private investors. The investment will enable Scalpel AI to scale its global operations and roll out its technology with major

Wobble Genomics unveils breakthrough early detection tech for breast cancer

Mercia Ventures-backed Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, will present data today demonstrating that its technology can detect rare full-length RNA transcript variants not picked up by other methods. 1 Wobble’s technology utilised full-length RNA transcripts as biomarkers to achieve early-stage breast cancer detection with 80% sensitivity

Mercia Asset Management PLC AGM Statement

Mercia Asset Management PLC is holding its Annual General Meeting at 10.00 am today. The Non-executive Chair, Ian Metcalfe, will make the following remarks at the meeting: “Mercia has made a positive start to the current financial year across both its equity and debt fund portfolios, including the Group’s five new British Business Bank mandates.